Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

VERAXA Biotech AG (NASDAQ: VRXA), Secarna Partnership Milestone Opens New Potential Market for Conjugation Technology

VERAXA Biotech (NASDAQ: VRXA), an emerging leader in designing novel cancer therapies, and Secarna Pharmaceuticals GmbH & Co. KG, a company redefining the discovery and development of best-in-class oligonucleotide therapeutics, have reached an early research milestone in their collaboration to develop antibody oligonucleotide conjugates (“AOCs”), providing VERAXA with an initial proof point for applying its […]

Regenerative Hydrogel Is Redefining Cartilage Repair as Regentis Advances GelrinC

Regenerative medicine is increasingly focused on a simple but ambitious goal: rather than simply treating damaged tissue, can medicine help the body rebuild it? Researchers are pursuing that question through a growing range of technologies, including stem cells, 3D bioprinting, tissue-engineered scaffolds and smart biomaterials. Unlike traditional implants that primarily replace or reinforce damaged structures, […]

Numa Numa Resources Inc. Advances Diversified Mining Portfolio Anchored by World-Class Copper and Gold

Disseminated on behalf of Numa Numa Resources Inc. and may include paid advertisements. The global mining industry is under real pressure to find and develop new sources of copper, gold and critical minerals as existing deposits deplete and new large-scale discoveries become harder to bring online. Numa Numa Resources is a mining and infrastructure development […]

American Fusion(TM) Inc. (AMFN) Builds Toward Commercial Fusion Market as Texatron(TM) Targets Rising Power Demand and Company Prepares for National Exchange Uplisting

American Fusion(TM) (OTC: AMFN), a developer of next-generation fusion energy technologies, is putting two pieces of its long-term strategy into sharper focus: developing the Texatron(TM) Fusion Engine(TM) for potential distributed-power applications while building the corporate and capital-markets infrastructure required for a possible national exchange listing. In an August 14 announcement, the Texas-based company provided an […]

Silynxcom Ltd. (NYSE American: SYNX) Is ‘One to Watch’

Silynxcom (NYSE American: SYNX) develops, manufactures and sells ruggedized tactical communication and hearing-protection systems designed for use in demanding environments. The company’s roots in acoustics and sound science extend back more than five decades, beginning with a family-founded music conservatory and subsequent work in hearing-aid development before that expertise was applied to tactical audio systems. Silynx […]

Silynxcom Ltd. (NYSE American: SYNX) Grows World Sales In a Rapidly Changing World, Fulfilling Increased Needs for Advanced Communication Headset System Technology

Whether you’re on the battlefield, in a tense SWAT operation, or working in a loud factory, hearing protection that keeps you safe, but doesn’t hurt your ability to hear your surroundings and communicate with others, is crucial to your success and comfort. Without an effective solution, you can miss critical commands, warnings, or other vital […]

India’s Medical-Device Market Surge Seen as Major Growth Opportunity for SS Innovations International Inc. (NASDAQ: SSII)

India’s next major manufacturing opportunity may emerge not from information technology or semiconductors, but from medical devices. An observation from business developer Shaad Merchant, quoting a recent report from Rubix Industry Insights, shows India’s medical-device market projected to increase from $15.2 billion in 2025 to $50.1 billion by 2030, representing a compound annual growth rate […]

Nano-X Imaging Ltd. (NASDAQ: NNOX) Is ‘One to Watch’

Nanox (NASDAQ: NNOX) is focused on driving the world’s transition to preventive health care by delivering an integrated, end-to-end medical imaging and healthcare services platform. Nanox combines affordable imaging hardware, advanced AI-based solutions, cloud-based software, access to remote radiology, health IT solutions, and a marketplace to enable earlier detection, improved clinical efficiency, and broader access to […]

MindWave Innovations Inc. (NYSE American: APUS) Is Helping Corporations Hold, Manage, and Generate Risk-Aware Yield on Bitcoin Reserves

As digital assets mature, the opportunity is increasingly extending beyond simply owning cryptocurrency. For corporations and institutional investors, the next challenge is building infrastructure that can help manage digital assets, generate potential returns and maintain appropriate financial controls. MindWave Innovations (NYSE American: APUS) is positioning itself around that transition. The digital asset and technology company […]

Frontieras North America Inc. Advances a Low-Sulfur Industrial Carbon That Heavy Industry Is Already Looking For

Coal has always been valued for what it produces when burned. Frontieras North America has built a business around what it produces when it isn’t burned. The company’s FASForm(TM) process fractionates coal into its molecular components without combustion, generating diesel, naphtha, jet fuel, ammonium sulfate fertilizer, sulfuric acid, and FASCarbon(TM), a solid carbon product with […]

 

From Our Blog

VERAXA Biotech AG (NASDAQ: VRXA), Secarna Partnership Milestone Opens New Potential Market for Conjugation Technology

August 27, 2026

VERAXA Biotech (NASDAQ: VRXA), an emerging leader in designing novel cancer therapies, and Secarna Pharmaceuticals GmbH & Co. KG, a company redefining the discovery and development of best-in-class oligonucleotide therapeutics, have reached an early research milestone in their collaboration to develop antibody oligonucleotide conjugates (“AOCs”), providing VERAXA with an initial proof point for applying its […]

Rotate your device 90° to view site.